CD19 and B-cell chronic lymphocytic leukemia: In line with these findings, patients treated with anti-CD19 CAR-T-cell therapy for CLL have experienced side effects like bacterial, viral, and fungal infections due to myelosuppression similar to patients suffering from other hematological malignancies (261).